Logo
  • Careers
  • Contact Us
  • Donate
  • Subscribe
Search
  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
    • Our History: 1995-2021
  • Our Work
    • Our Work
    • Discovery & Research
      • Antibody Translational Research Program
      • Human Immunology Laboratory
      • IAVI Neutralizing Antibody Center
      • Vaccine Design and Development Laboratory
      • Clinical Research Centers
      • Clinical Research Standards
      • Observational Epidemiology Studies
      • IAVI in Africa
    • Translation & Product Development
    • Global Access to Scientific Innovations
    • ADVANCE
      • IAVI DataSpace
    • Advocacy & Community Engagement
      • CASPR
      • Tuberculosis R&D Advocacy
      • World Bank/Japan-supported
        Partnerships | 日本政府・世銀が支援するパートナーシップ
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • Vaccine Literacy Library
    • VOICES Newsletter
    • Multimedia
    • Media Contacts
    • Subscribe
  • Careers
  • Contact Us
  • Donate
  • Subscribe

Search

  • Home
  • About
    • About
    • Board of Directors
    • Senior Leadership
    • Financial Statements
    • Global Funding & Support
    • Our History: 1995-2021
  • Our Work
    • Our Work
    • Discovery & Research
    • Translation & Product Development
    • Global Access to Scientific Innovations
    • ADVANCE
    • Advocacy & Community Engagement
  • Our Science
    • Our Science
    • Pipeline
    • HIV Vaccines
    • bnAbs for HIV Prevention
    • Tuberculosis Vaccines
    • Emerging Infectious Diseases Vaccines
  • News & Resources
    • Latest NewsLatest News
    • Scientific Publications Scientific Publications
    • Press Releases
    • Features
    • IAVI Report
    • IAVI in the News
    • Fact Sheets & Publications
    • Vaccine Literacy Library
    • VOICES Newsletter
    • Multimedia
    • Media Contacts
    • Subscribe
  • Latest NewsLatest News
  • Scientific Publications Scientific Publications
  • Press Releases
  • Features
  • IAVI Report
  • IAVI in the News
  • Fact Sheets & Publications
  • Vaccine Literacy Library
  • VOICES Newsletter
  • Multimedia
  • Media Contacts
  • Subscribe

Latest News

Filter By:

International Women's Day 2023
FEATURES
March 7, 2023

Why we need women leaders in science and research

Aaron Wilson, research scientist, working on vaccine development at IAVI’s Vaccine Design & Development Lab
PRESS RELEASES
March 2, 2023

IAVI and BARDA expand partnership to advance IAVI’s filovirus vaccine candidates

Ministry of Foreign Affairs of the Netherlands
FEATURES
February 22, 2023

The Netherlands renews their support to IAVI for the development of new HIV prevention technologies

Press Releases

March 2, 2023

IAVI and BARDA expand partnership to advance IAVI’s filovirus vaccine candidates

December 2, 2022

Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach

October 25, 2022

IAVI to accelerate promising investigational Sudan ebolavirus vaccine development for potential outbreak research and response

August 31, 2022

IAVI announces first vaccinations at Liberia site in Phase I clinical trial of Lassa fever vaccine candidate

August 29, 2022

Japan reiterates commitment to HIV vaccine development with a $10.5 million contribution to IAVI

See all Press Releases

Features

March 9, 2023

IAVI kicks off second cohort of Leadership Development Program

March 7, 2023

Why we need women leaders in science and research

March 6, 2023

New tuberculosis vaccines needed to tackle antimicrobial resistance

February 22, 2023

The Netherlands renews their support to IAVI for the development of new HIV prevention technologies

February 7, 2023

New IAVI-authored paper proposes additional regulatory pathways for filovirus vaccines

See all Features

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org 

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Smriti Bhagi
+91 11 4737 6025
SBhagi@iavi.org 

 

North America

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org 

About

About

Board of Directors

Senior Leadership

Financial Statements

Global Funding & Support

Our History: 1995-2021

Our Work

Our Work

Discovery & Research

Translation & Product Development

Global Access to Scientific Innovations

ADVANCE

Advocacy & Community Engagement

Our Science

Our Science

Pipeline

HIV Vaccines

bnAbs for HIV Prevention

Tuberculosis Vaccines

Emerging Infectious Diseases Vaccines

News & Resources

Latest NewsLatest News

Scientific Publications Scientific Publications

Press Releases

Features

IAVI Report

IAVI in the News

Fact Sheets & Publications

Vaccine Literacy Library

VOICES Newsletter

Multimedia

Media Contacts

Subscribe

icon iaviIAVI guidestar platinum seal 2021 IAVI Charity Navigator 2021

Accessibility

Compliance/RFPs

Contact IAVI

Privacy Policy

Site Map

Supplier Diversity

Terms of Use

©2023 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the International AIDS Vaccine Initiative, Inc.